• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Evaluation of Esophageal Anastomotic Stricture Dilations after Transhiatal Esophagectomy for Esophageal Cancer

Evaluation of Esophageal Anastomotic Stricture Dilations after Transhiatal Esophagectomy for Esophageal Cancer

Robert D Andres, MD, PhD, Valerie Wu Chao Ying, MD, Jose M Martinez, MD, FACS. University of Miami – Miller School of Medicine / Jackson Memorial Hospital

INTRODUCTION: Esophageal anastomotic stricture is a well described complication after transhiatal esophagectomy (THE). We have recently examined the management and provided treatment recommendations after the initial endoscopic therapy for esophageal stricture after THE. Here we expand upon those findings examining the effects of cancer stage, neoadjuvant treatment and post operative complications on esophageal dilations.

METHODS: We performed a retrospective review of one surgeon’s experience with esophageal dilations after THE between 2009 – 2013. Patient demographics: n = 43, age = 59, 95% male, 5% female. Patients with T3 lesions and/or node positive received either neoadjuvant chemotherapy or chemoradiation and restaged prior to surgical intervention. Two surgeons performed THE, either thru an open or laparoscopic approach, and one surgeon performed all endoscopic therapies.

RESULTS: For all cases, average: number of dilations, time since surgery, time since first dilation and time between each dilation was: 3.67, 313 days, 197 days and 44 days, respectively. The effect of neoadjuvant therapy was evaluated. No neoadjuvant vs neoadjuvant therapy: number of dilations: 3.50 vs 3.88; time since surgery: 282 vs 343 days; time since first dilation: 189 vs 211 days; and time between each dilation: 39 vs 61 days. Post operative complications requiring intervention (eg wound infection/drainage, abscess, fistula) were also evaluated: number of dilations: 2.96 vs 5.07; time since first surgery: 270 vs 416 days; time since first dilation: 143 vs 318 days; and time between each dilation: 42 vs 77 days. For all cases, the time between the penultimate and final dilation was 105 days. For those patients undergoing multiple dilations (>3), the time between the penultimate and final dilation was 171 days. Additionally, for those receiving >3, there was no discernable difference in the number of days of between each dilation for those receiving neoadjuvant chemotherapy compared to those with post operative complications.

CONCLUSION(S): Our results demonstrate that patient’s with higher stages of esophageal cancer who receive neoadjuvant modalities require more frequent dilations and a longer course of endoscopic management. Furthermore, a post operative complication after a THE, regardless of the cancer staging or neoadjuvant course, on average will double the number of dilations and total time of therapy.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 80365

Program Number: P340

Presentation Session: Poster (Non CME)

Presentation Type: Poster

44

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals